Dorp, S. V., Stussi, G., Frustaci, A. M., Flinn, I., Crees, Z., Baird, J., Mountjoy, L., Dahiya, S., Kutsch, N., Zinzani, P. L., Lopez-Guillermo, A., Staber, P., Ysebaert, L., García-Sanz, R., Vicente, F. D. L. C., Leslie, L., Bond, D., Dholaria, B., Williams, C., Zhou, L., Kloos, I., Nikolaenko, L., Tiacci, E. (2025). ZUMA-25 preliminary analysis: A Phase 2 study of brexucabtagene autoleucel (brexu-cel) in patients (Pts) with relapsed/refractory (R/R) burkitt lymphoma (BL), substudy C. Blood. https://doi.org/10.1182/blood-2025-569